APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lomustine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lomustine Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchLomustine Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Lomustine Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Lomustine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lomustine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lomustine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lomustine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lomustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lomustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lomustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lomustine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lomustine market include Zhongfu Pharma, Nanjing Pharma, Bristol-Myers Squibb, Ther Dose, NextSource Pharma, Miracalus Pharma, Medicon Pharma and ACTIZA, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Lomustine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lomustine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lomustine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Lomustine market.

Lomustine Segment by Company

Zhongfu Pharma

Nanjing Pharma

Bristol-Myers Squibb

Ther Dose

NextSource Pharma

Miracalus Pharma

Medicon Pharma

ACTIZA

Lomustine Segment by Type

10mg/Tablet

40mg/Tablet

100mg/Tablet

Lomustine Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Lomustine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lomustine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Lomustine key companies, revenue, market share, and recent developments.

3. To split the Lomustine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Lomustine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lomustine significant trends, drivers, influence factors in global and regions.

6. To analyze Lomustine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lomustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lomustine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lomustine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lomustine industry.

Chapter 3: Detailed analysis of Lomustine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Lomustine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Lomustine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lomustine Industry Trends Table 2. Lomustine Industry Drivers Table 3. Lomustine Industry Opportunities and Challenges Table 4. Lomustine Industry Restraints Table 5. Global Lomustine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lomustine Revenue Share by Company (2021-2026) Table 7. Global Lomustine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Lomustine Key Company Manufacturing Base & Headquarters Table 9. Global Lomustine Company, Product Type & Application Table 10. Global Lomustine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Lomustine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 10mg/Tablet Table 15. Significant Companies of 40mg/Tablet Table 16. Significant Companies of 100mg/Tablet Table 17. Global Lomustine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Lomustine Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Lomustine Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Lomustine Sales Value Share by Type (2021-2026) Table 21. Global Lomustine Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Pharmacies Table 23. Significant Companies of Online Pharmacies Table 24. Significant Companies of Retail Pharmacies Table 25. Global Lomustine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lomustine Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Lomustine Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Lomustine Sales Value Share by Application (2021-2026) Table 29. Global Lomustine Sales Value Share by Application (2027-2032) Table 30. Global Lomustine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Lomustine Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Lomustine Sales Value Share by Region (2021-2026) Table 33. Global Lomustine Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Lomustine Sales Value Share by Region (2027-2032) Table 35. Global Lomustine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Lomustine Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Lomustine Sales Value Market Share by Country (2021-2026) Table 38. Global Lomustine Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Lomustine Sales Value Market Share by Country (2027-2032) Table 40. Zhongfu Pharma Company Information Table 41. Zhongfu Pharma Business Overview Table 42. Zhongfu Pharma Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Zhongfu Pharma Lomustine Product Portfolio Table 44. Zhongfu Pharma Recent Development Table 45. Nanjing Pharma Company Information Table 46. Nanjing Pharma Business Overview Table 47. Nanjing Pharma Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Nanjing Pharma Lomustine Product Portfolio Table 49. Nanjing Pharma Recent Development Table 50. Bristol-Myers Squibb Company Information Table 51. Bristol-Myers Squibb Business Overview Table 52. Bristol-Myers Squibb Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Bristol-Myers Squibb Lomustine Product Portfolio Table 54. Bristol-Myers Squibb Recent Development Table 55. Ther Dose Company Information Table 56. Ther Dose Business Overview Table 57. Ther Dose Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Ther Dose Lomustine Product Portfolio Table 59. Ther Dose Recent Development Table 60. NextSource Pharma Company Information Table 61. NextSource Pharma Business Overview Table 62. NextSource Pharma Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. NextSource Pharma Lomustine Product Portfolio Table 64. NextSource Pharma Recent Development Table 65. Miracalus Pharma Company Information Table 66. Miracalus Pharma Business Overview Table 67. Miracalus Pharma Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Miracalus Pharma Lomustine Product Portfolio Table 69. Miracalus Pharma Recent Development Table 70. Medicon Pharma Company Information Table 71. Medicon Pharma Business Overview Table 72. Medicon Pharma Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Medicon Pharma Lomustine Product Portfolio Table 74. Medicon Pharma Recent Development Table 75. ACTIZA Company Information Table 76. ACTIZA Business Overview Table 77. ACTIZA Lomustine Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. ACTIZA Lomustine Product Portfolio Table 79. ACTIZA Recent Development Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Lomustine Product Image Figure 2. Global Lomustine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lomustine Market Size (2021-2032) & (US$ Million) Figure 4. Global Lomustine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 10mg/Tablet Image Figure 8. 40mg/Tablet Image Figure 9. 100mg/Tablet Image Figure 10. Global Lomustine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Lomustine Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Lomustine Sales Value Share by Type (2021-2032) Figure 13. Hospital Pharmacies Image Figure 14. Online Pharmacies Image Figure 15. Retail Pharmacies Image Figure 16. Global Lomustine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Lomustine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Lomustine Sales Value Share by Application (2021-2032) Figure 19. Global Lomustine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Lomustine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Lomustine Sales Value (2021-2032) & (US$ Million) Figure 22. North America Lomustine Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Lomustine Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Lomustine Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Lomustine Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Lomustine Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Lomustine Sales Value (2021-2032) & (US$ Million) Figure 28. South America Lomustine Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Lomustine Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Lomustine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Lomustine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Lomustine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Lomustine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/Tablet
  • 40mg/Tablet
  • 100mg/Tablet
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Zhongfu Pharma
  • Nanjing Pharma
  • Bristol-Myers Squibb
  • Ther Dose
  • NextSource Pharma
  • Miracalus Pharma
  • Medicon Pharma
  • ACTIZA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lomustine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lomustine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Lomustine Market Dynamics
  1. 2.1 Lomustine Industry Trends
  2. 2.2 Lomustine Industry Drivers
  3. 2.3 Lomustine Industry Opportunities and Challenges
  4. 2.4 Lomustine Industry Restraints
3 Lomustine Market by Company
  1. 3.1 Global Lomustine Company Revenue Ranking in 2025
  2. 3.2 Global Lomustine Revenue by Company (2021-2026)
  3. 3.3 Global Lomustine Company Ranking (2024-2026)
  4. 3.4 Global Lomustine Company Manufacturing Base and Headquarters
  5. 3.5 Global Lomustine Company Product Type and Application
  6. 3.6 Global Lomustine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Lomustine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Lomustine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Lomustine Market by Type
  1. 4.1 Lomustine Type Introduction
  2. 4.1.1 10mg/Tablet
  3. 4.1.2 40mg/Tablet
  4. 4.1.3 100mg/Tablet
  5. 4.2 Global Lomustine Sales Value by Type
  6. 4.2.1 Global Lomustine Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Lomustine Sales Value by Type (2021-2032)
  8. 4.2.3 Global Lomustine Sales Value Share by Type (2021-2032)
5 Lomustine Market by Application
  1. 5.1 Lomustine Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Lomustine Sales Value by Application
  6. 5.2.1 Global Lomustine Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lomustine Sales Value by Application (2021-2032)
  8. 5.2.3 Global Lomustine Sales Value Share by Application (2021-2032)
6 Lomustine Regional Value Analysis
  1. 6.1 Global Lomustine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lomustine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Lomustine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Lomustine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lomustine Sales Value (2021-2032)
  7. 6.3.2 North America Lomustine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Lomustine Sales Value (2021-2032)
  10. 6.4.2 Europe Lomustine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Lomustine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Lomustine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Lomustine Sales Value (2021-2032)
  16. 6.6.2 South America Lomustine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Lomustine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Lomustine Sales Value Share by Country, 2025 VS 2032
7 Lomustine Country-level Value Analysis
  1. 7.1 Global Lomustine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lomustine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Lomustine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Lomustine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Lomustine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Lomustine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Lomustine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Lomustine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Lomustine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Lomustine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Lomustine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Lomustine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Lomustine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Lomustine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Lomustine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Lomustine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Lomustine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Lomustine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Lomustine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Lomustine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Lomustine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Lomustine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Lomustine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Lomustine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Lomustine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Lomustine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Lomustine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Lomustine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Lomustine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Lomustine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Lomustine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Lomustine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Lomustine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Lomustine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Lomustine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Lomustine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Lomustine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Lomustine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Lomustine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Lomustine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Lomustine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Lomustine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Lomustine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Lomustine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Lomustine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Lomustine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Lomustine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Lomustine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Lomustine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Lomustine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Lomustine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Lomustine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Lomustine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Lomustine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Lomustine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Lomustine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Lomustine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Lomustine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Lomustine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Lomustine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Lomustine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Lomustine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Lomustine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Lomustine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Lomustine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Lomustine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Lomustine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Lomustine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Lomustine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Lomustine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Lomustine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Lomustine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Lomustine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Lomustine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Lomustine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Lomustine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Lomustine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Lomustine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Lomustine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Lomustine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Lomustine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Lomustine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Lomustine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Lomustine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Lomustine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Lomustine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Lomustine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Lomustine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongfu Pharma
  2. 8.1.1 Zhongfu Pharma Company Information
  3. 8.1.2 Zhongfu Pharma Business Overview
  4. 8.1.3 Zhongfu Pharma Lomustine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhongfu Pharma Lomustine Product Portfolio
  6. 8.1.5 Zhongfu Pharma Recent Developments
  7. 8.2 Nanjing Pharma
  8. 8.2.1 Nanjing Pharma Company Information
  9. 8.2.2 Nanjing Pharma Business Overview
  10. 8.2.3 Nanjing Pharma Lomustine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nanjing Pharma Lomustine Product Portfolio
  12. 8.2.5 Nanjing Pharma Recent Developments
  13. 8.3 Bristol-Myers Squibb
  14. 8.3.1 Bristol-Myers Squibb Company Information
  15. 8.3.2 Bristol-Myers Squibb Business Overview
  16. 8.3.3 Bristol-Myers Squibb Lomustine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Lomustine Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Recent Developments
  19. 8.4 Ther Dose
  20. 8.4.1 Ther Dose Company Information
  21. 8.4.2 Ther Dose Business Overview
  22. 8.4.3 Ther Dose Lomustine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ther Dose Lomustine Product Portfolio
  24. 8.4.5 Ther Dose Recent Developments
  25. 8.5 NextSource Pharma
  26. 8.5.1 NextSource Pharma Company Information
  27. 8.5.2 NextSource Pharma Business Overview
  28. 8.5.3 NextSource Pharma Lomustine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NextSource Pharma Lomustine Product Portfolio
  30. 8.5.5 NextSource Pharma Recent Developments
  31. 8.6 Miracalus Pharma
  32. 8.6.1 Miracalus Pharma Company Information
  33. 8.6.2 Miracalus Pharma Business Overview
  34. 8.6.3 Miracalus Pharma Lomustine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Miracalus Pharma Lomustine Product Portfolio
  36. 8.6.5 Miracalus Pharma Recent Developments
  37. 8.7 Medicon Pharma
  38. 8.7.1 Medicon Pharma Company Information
  39. 8.7.2 Medicon Pharma Business Overview
  40. 8.7.3 Medicon Pharma Lomustine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Medicon Pharma Lomustine Product Portfolio
  42. 8.7.5 Medicon Pharma Recent Developments
  43. 8.8 ACTIZA
  44. 8.8.1 ACTIZA Company Information
  45. 8.8.2 ACTIZA Business Overview
  46. 8.8.3 ACTIZA Lomustine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ACTIZA Lomustine Product Portfolio
  48. 8.8.5 ACTIZA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst